Status:
UNKNOWN
Sarcopenia and Physical Performance in Hemodialysis Patients
Lead Sponsor:
Hacettepe University
Conditions:
End Stage Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
Many systems such as the cardiovascular, pulmonary, musculoskeletal, hematological, immunological, gastrointestinal, central nervous system are affected due to decreased kidney function. The aim of th...
Detailed Description
A high prevalence of sarcopenia has been reported in end stage kidney disease. The incidence of sarcopenia increases with age. Muscle atrophy is caused by an imbalance between the anabolic and catabol...
Eligibility Criteria
Inclusion
- Having been diagnosed with end stage kidney disease
- Receiving hemodialysis for more than 3 months
- Being clinically stable
- Volunteering to participate in the research
Exclusion
- Having an orthopedic disease that may affect functional capacity
- Having cardiac event in the past 3 months
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04669184
Start Date
January 1 2021
End Date
March 1 2022
Last Update
December 16 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.